{
  "url": "https://openlegislation.uk/eu-decision-2020-569/annex-I/part-A",
  "json_url": "https://openlegislation.uk/eu-decision-2020-569/annex-I/part-A.json",
  "legislation": "eudn/2020/569",
  "legislation_title": "Commission Implementing Decision (EU) 2020/569 of 16 April 2020 establishing a common format and information content for the submission of the information to be reported by Member States pursuant to Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes and repealing Commission Implementing Decision 2012/707/EU (notified under document C(2020) 2179) (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2020-569",
  "path": "annex/I/part/A",
  "kind": "part",
  "number": "A",
  "heading": "Template for the submission of non-technical project summaries referred to in article 43(1) of directive 2010/63/EU",
  "text": "Including scientific terms which may consist of more than 5 individual words and excluding species and purposes entered elsewhere in the document\nTo be provided via a dropdown menu\nList of purposes in accordance with statistical reporting categories and sub-categories in Annex III to this Decision\nSpecies in accordance with statistical reporting categories in Annex III to this Decision, with an additional option of ‘non-specified mammal’ to safeguard anonymity in exceptional cases\nSpecies to be populated from the previous response to select from under the relevant category (proportions)\nMultiple choices per species possible\nMultiple choices possible; applicable to those MS where this information is required by the legislation\nTitle of the project\nDuration of project\n(in months)\nKey Words (maximum of 5)\nPurpose of project\n(multiple choices possible)\nBasic research\nTranslational and applied research\nRegulatory use and routine production:\nQuality control (including batch safety and potency testing)\nOther efficacy and tolerance testing\nToxicity and other safety testing including pharmacology\nRoutine production\nProtection of the natural environment in the interests of the health or welfare of human beings or animals\nPreservation of species\nHigher education\nTraining\nForensic enquiries\nMaintenance of colonies of genetically altered animals, not used in other procedures\nObjectives and predicted benefits of the project\nDescribe the objectives of the project (for example, addressing certain scientific unknowns, or scientific or clinical needs).\nWhat are the potential benefits likely to derive from this project? Explain how science could be advanced, or humans, animals or environment may ultimately benefit from the project. Where applicable, differentiate between short-term benefits (within the duration of the project) and long-term benefits (which may accrue after the project is finished).\nPredicted harms\nIn what procedures will the animals typically be used (for example, injections, surgical procedures)? Indicate the number and duration of these procedures.\nWhat are the expected impacts/adverse effects on the animals, for example pain, weight loss, inactivity/reduced mobility, stress, abnormal behaviour, and the duration of those effects?\nWhat species and numbers of animals are expected to be used? What are the expected severities and the numbers of animals in each severity category (per species)?\nSpecies\nEstimated total numbers\nEstimated numbers per severity\nNon-recovery\nMild\nModerate\nSevere\nWhat will happen to the animals kept alive at the end of the procedure? ,\nEstimated number to be reused\nEstimated number to be returned to habitat/husbandry system\nEstimated number to be rehomed\nPlease provide reasons for the planned fate of the animals after the procedure.\nApplication of the Three Rs\n1. Replacement\nState which non-animal alternatives are available in this field and why they cannot be used for the purposes of the project.\n2. Reduction\nExplain how the numbers of animals for this project were determined. Describe steps that have been taken to reduce the number of animals to be used, and principles used to design studies. Where applicable, describe practices that will be used throughout the project to minimise the number of animals used consistent with scientific objectives. Those practices may include e.g. pilot studies, computer modelling, sharing of tissue and reuse.\n3. Refinement\nGive examples of the specific measures (e.g., increased monitoring, post-operative care, pain management, training of animals) to be taken, in relation to the procedures, to minimise welfare costs (harms) to the animals. Describe the mechanisms to take up emerging refinement techniques during the lifetime of the project.\nExplain the choice of species and the related life stages.\nProject selected for Retrospective Assessment\nDeadline\nContains severe procedures\nUses non-human primates\nOther reason",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Including scientific terms which may consist of more than 5 individual words and excluding species and purposes entered elsewhere in the document"
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "To be provided via a dropdown menu"
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "List of purposes in accordance with statistical reporting categories and sub-categories in Annex III to this Decision"
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "Species in accordance with statistical reporting categories in Annex III to this Decision, with an additional option of ‘non-specified mammal’ to safeguard anonymity in exceptional cases"
    },
    {
      "type": "footnote",
      "label": "f5",
      "text": "Species to be populated from the previous response to select from under the relevant category (proportions)"
    },
    {
      "type": "footnote",
      "label": "f6",
      "text": "Multiple choices per species possible"
    },
    {
      "type": "footnote",
      "label": "f7",
      "text": "Multiple choices possible; applicable to those MS where this information is required by the legislation"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2020/569/annex/I/part/A",
    "retrieved_at": "2026-11-01T15:12:17.611205+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}